术前影像学方法评估胰腺囊性病变恶性潜能的比较:一项网络Meta分析
该网络Meta分析纳入17项直接比较研究共1018例患者,比较多种术前影像学方法鉴别胰腺囊性病变良恶性的诊断性能。结果显示,18F-FDG PET的阳性预测值和准确率显著高于CT或MRI,在全部胰腺囊性病变及仅导管内乳头状黏液性肿瘤的亚组分析中均如此。作者认为18F-FDG PET是鉴别胰腺囊性病变良恶性的最佳术前影像学方法,可用于术前评估。
要点
- 18F-FDG PET鉴别胰腺囊性病变良恶性的阳性预测值和准确率显著高于CT或MRI。
- 在仅导管内乳头状黏液性肿瘤的亚组分析中,18F-FDG PET的优势同样成立。
- 18F-FDG PET在敏感度、特异度、阳性预测值、阴性预测值和准确率各诊断性能领域的累积排序曲线下面积值均最高。
核心结论
- 该网络Meta分析结果提示,18F-FDG PET是鉴别胰腺囊性病变良恶性的最佳术前影像学方法,可用于胰腺囊性病变的术前评估。
研究设计与样本
- 检索PubMed、EMBASE和Cochrane Library中评估术前影像学方法识别恶性胰腺囊性病变性能的研究。
- 共纳入17项使用2种或以上术前影像学方法的直接比较研究、1018例患者,用于鉴别恶性与良性胰腺囊性病变。
- 对4类代表性影像学方法进行网络Meta分析,并以仅导管内乳头状黏液性肿瘤作为亚组分析;通过累积排序曲线下面积值计算各影像学方法成为最有效诊断方法的概率。
主要发现
- 在全部胰腺囊性病变中,18F-FDG PET的阳性预测值显著高于CT(OR 2.66,95% CrI 1.21-6.17),准确率也显著高于CT(OR 2.63,95% CrI 1.41-5.38)。
- 在全部胰腺囊性病变中,18F-FDG PET的阳性预测值显著高于MRI(OR 2.50,95% CrI 1.09-6.26),准确率也显著高于MRI(OR 2.50,95% CrI 1.28-5.47)。
- 在仅导管内乳头状黏液性肿瘤的亚组分析中,18F-FDG PET的阳性预测值和准确率同样显著高于CT或MRI。
- 18F-FDG PET在敏感度、特异度、阳性预测值、阴性预测值和准确率所有诊断性能领域的累积排序曲线下面积值均最高,其后为MRI或CT。
关键数值与推荐
- 18F-FDG PET对比CT:阳性预测值OR 2.66(95% CrI 1.21-6.17),准确率OR 2.63(95% CrI 1.41-5.38)。
- 18F-FDG PET对比MRI:阳性预测值OR 2.50(95% CrI 1.09-6.26),准确率OR 2.50(95% CrI 1.28-5.47)。
临床怎么用
- 作者认为,18F-FDG PET是鉴别胰腺囊性病变良恶性的最佳术前影像学方法,可用于胰腺囊性病变的术前评估。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The aims of this study are to compare the performance of various preoperative imaging modalities for assessing the malignant potential of pancreatic cystic lesions (PCLs) through a network meta-analysis (NMA) and to clarify the role of 18 F-FDG PET in the management of patients with PCL. METHODS: PubMed, EMBASE, and Cochrane Library were searched for the studies evaluating the performance of preoperative imaging modalities for identifying malignant PCLs. The NMA was performed for 4 representative categories of various imaging modalities in terms of diagnostic performance for differentiating malignant from benign PCL and intraductal papillary mucinous neoplasms only as a subgroup analysis. To calculate the probability of each imaging modality being the most effective diagnostic method, the surface under the cumulative ranking curve values were obtained. RESULTS: A total of 1018 patients from 17 direct comparison studies using 2 or more preoperative imaging modalities were included for differentiating malignant from benign PCL. The positive predictive value (PPV) and accuracy of 18 F-FDG PET were significantly higher than that of CT (PPV: odds ratio [OR], 2.66; 95% credible interval [CrI], 1.21-6.17; accuracy: OR, 2.63; 95% CrI, 1.41-5.38) or MRI (PPV: OR, 2.50; 95% CrI, 1.09-6.26; accuracy: OR, 2.50; 95% CrI, 1.28-5.47) in all PCLs, as well as in the subgroup analysis for intraductal papillary mucinous neoplasm only. 18 F-FDG PET showed the highest surface under the cumulative ranking curve values in all diagnostic performance areas of sensitivity, specificity, PPV, negative predictive value, and accuracy, followed by MRI or CT. CONCLUSIONS: The results from this NMA suggest that 18 F-FDG PET is the best preoperative imaging modality for differentiating malignant from benign PCLs and that it can be used for the preoperative evaluation of PCLs.
引用
- Lee SW, Shim SR, Jeong SY, et al. Comparison of Preoperative Imaging Modalities for the Assessment of Malignant Potential of Pancreatic Cystic Lesions: A Network Meta-analysis. Clin Nucl Med. 2022. PMID: 35713890. doi:10.1097/RLU.0000000000004323
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。